AstraZeneca, one of the UK's most valuable companies, is reportedly considering leaving the country—a move that would rattle both the government and London's financial hub. The mere possibility has sparked alarm, hinting at deeper concerns about the UK's business climate.

Editor’s Note: Losing a giant like AstraZeneca wouldn't just be a symbolic blow—it could signal wider unease among global firms about operating in the UK. For the government, it’s a wake-up call; for the City, it’s a potential domino effect waiting to happen. If even homegrown success stories are eyeing the exit, who's next?